Sign In

An official website of the United States government

U.S. Department of Health & Human Services

Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

COVID-19 Therapeutic Product Expiration Dates

The U.S. Food and Drug Administration authorized an extension to the shelf life for certain lots of COVID-19 therapeutic products. The following table lists the original dates and, if applicable, extension expiration dates for the following COVID-19 therapeutic products: bamlanivimab, bebtelovimab, etesevimab, Evusheld, Lagevrio (molnupiravir), REGEN-COV, and sotrovimab.

As of March 9, 2024, EUA-labeled Paxlovid (nirmatrelvir co-packaged with ritonavir) no longer authorized for use, regardless of expiry data.

Learn more about shelf-life extensions and other COVID-19 therapeutic information in the Important Updates.

How to Use the Searchable COVID-19 Therapeutics Expiry Database

  • Expand to see the list for the product of interest by clicking the word “Product”
  • Sort by lot number, labelled expiry, or extended expiry by selecting the desired filter at the top of the column.
  • Search for a specific lot number by entering the full number in the “Find an item” search bar, be sure to expand the product list to see your result.
  • For more information, please see the disclaimers and footnotes at the bottom of this page.



Download All Entries 33KB XLS

Disclaimers and Footnotes

  • Data source(s): Manufacturers and/or FDA Website
  • Last Updated: June 14, 2023
  • Paxlovid (nirmatrelvir co-packaged with ritonavir) expiry data available at https://www.paxlovidlotexpiry.com
  • REGEN-COV expiry occurs on the last day of the listed month.
  • Sotrovimab expiry occurs on the last day of the listed month.
  • Bebtelovimab includes all lots (USG purchased lots, commercially purchased lots, and replacement lots).
  • Veklury (remdesivir) is available only commercially and is not included in this resource.
  • Blank cells for extended expiry indicate no extension received for specified lot.
  • Download an accessible excel file of the COVID-19 therapeutics expiration information.